Trials / Recruiting
RecruitingNCT02655302
Study of the Involvement of IL-17 / IL-22 Pathway in Bacterial Exacerbations of COPD
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- University Hospital, Lille · Academic / Other
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
Chronic obstructive pulmonary disease (COPD) is a worldwide chronic inflammatory disease of the airways linked to environmental exposure. The chronic course of COPD is often interrupted by acute exacerbations which have a major impact on the morbidity and mortality of COPD patients. A bacterial etiology for these exacerbations is common (almost 50%). Moreover, airway bacterial colonization linked to an increased susceptibility is observed in COPD patients. Effective Th17 immune response is needed to develop a good response against bacteria. Thus, this study aims to demonstrate that there is a defective IL-17/ IL-22 response to bacteria in COPD leading to airway bacterial colonization and infection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Sample collecting | Collect sputum, blood and nasopharyngeal swab during the exacerbation and at steady state 8 to 16 weeks later. |
| OTHER | Lung function measure | Measure lung function and follow it during 4 years |
Timeline
- Start date
- 2018-07-04
- Primary completion
- 2028-07-01
- Completion
- 2028-07-01
- First posted
- 2016-01-14
- Last updated
- 2023-01-27
Locations
4 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02655302. Inclusion in this directory is not an endorsement.